Recent News for OCX - OncoCyte Corporation

Date Title
May 13 Oncocyte Announces New Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting Demonstrating That the DetermaIO™ Gene Expression Test May Predict Response to Immunotherapy in Triple Negative Breast Cancer
May 13 Edited Transcript of OCX earnings conference call or presentation 12-May-20 8:30pm GMT
May 13 Oncocyte Corporation (OCX) CEO Ronald Andrews on Q1 2020 Results - Earnings Call Transcript
May 12 OncoCyte EPS misses by $0.02
May 12 Oncocyte Provides Corporate Update And Reports First Quarter 2020 Financial Results
May 12 The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
May 10 The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
May 5 Oncocyte Announces Peer-Reviewed Publication of Data Demonstrating the Potential of its TNBCType Assay to Inform Triple Negative Breast Cancer Drug Development
May 5 Oncocyte to Report First Quarter 2020 Financial Results on Tuesday, May 12
May 1 Oncocyte Announces the Publication of New Long-Term Patient Follow Up Data for DetermaRx™ and Research Describing the IRENE Cohort Being Used in the Development of DetermaDx™
Apr 24 Oncocyte up 15% premarket on $10.7M registered offering
Apr 24 Oncocyte Announces $10.7 Million Registered Offering
Apr 23 Oncocyte inks distribution deal for DetermaRx
Apr 23 Oncocyte Announces Distribution Agreement with CORE Diagnostics, Expanding Commercial Availability of DetermaRx™ to India, the Middle East and Africa
Apr 7 Read This Before Selling OncoCyte Corporation (NYSEMKT:OCX) Shares
Apr 7 Medical Services Outlook Bright Amid Coronavirus Crisis
Apr 7 Oncocyte to Participate at 19th Annual Needham Virtual Healthcare Conference
Mar 26 Edited Transcript of OCX earnings conference call or presentation 25-Mar-20 8:30pm GMT
Mar 26 OncoCyte Corporation (OCX) CEO Ronald Andrews on Q4 2019 Results - Earnings Call Transcript
Mar 25 OncoCyte EPS misses by $0.06
Mar 25 ONCOCYTE PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS
Mar 25 OncoCyte Corp. to Host Earnings Call
Mar 25 The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
Mar 25 Earnings Scheduled For March 25, 2020
Mar 22 The Week Ahead In Biotech: Bristol-Myers, Rockwell Medical Await FDA Decisions, COVID-19 Updates In Focus

Back to the Main OCX Page...